BOLT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Bolt Biotherapeutics Inc (BOLT) is not a strong buy for a beginner, long-term investor at the moment. The stock shows bearish technical indicators, weak financial performance, and lacks positive catalysts or trading signals. Given the user's impatience and unwillingness to wait for optimal entry points, holding off on this investment is recommended until stronger signals or catalysts emerge.
The technical indicators are bearish. The MACD is positive but contracting, RSI is neutral at 46.745, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below key support levels, with a pivot at 4.433 and the next support at 4.109.
No recent news, no positive trading trends, and no significant signals from proprietary trading tools.
The stock experienced a -4.88% drop in the regular market and a -2.00% pre-market change. Financial performance is weak, with a significant YoY drop in net income (-58.39%) and EPS (-53.85%). No recent insider or hedge fund activity, and no recent congress trading data.
In Q4 2025, revenue remained flat at $2,500,000 YoY. Net income dropped significantly to -$6,631,000 (-58.39% YoY), and EPS decreased to -3.84 (-53.85% YoY). Gross margin remained unchanged at 100%. Overall, the company's financial performance is weak and shows no growth trends.
No recent analyst rating or price target changes available.
